Jianping Wu

626 total citations
36 papers, 484 citations indexed

About

Jianping Wu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Jianping Wu has authored 36 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Jianping Wu's work include Ferroptosis and cancer prognosis (4 papers), Renal cell carcinoma treatment (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Jianping Wu is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Renal cell carcinoma treatment (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Jianping Wu collaborates with scholars based in China, Australia and United Kingdom. Jianping Wu's co-authors include Yu‐Zheng Ge, Ruiyang Wu, Jiageng Zhu, Liuhua Zhou, Yu Peng, Yan Zhao, Weipu Mao, Ming Chen, Rui-Peng Jia and Hui Xin and has published in prestigious journals such as PLoS ONE, Scientific Reports and Gene.

In The Last Decade

Jianping Wu

32 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianping Wu China 14 166 135 101 80 75 36 484
Dandan He China 14 137 0.8× 133 1.0× 52 0.5× 30 0.4× 90 1.2× 24 521
Jianfeng Xu China 14 149 0.9× 50 0.4× 130 1.3× 84 1.1× 51 0.7× 25 570
Yufu Li China 12 110 0.7× 55 0.4× 57 0.6× 47 0.6× 99 1.3× 54 479
Francesca Bruno Italy 18 282 1.7× 116 0.9× 55 0.5× 63 0.8× 52 0.7× 76 1.2k
Henry Penn United Kingdom 15 231 1.4× 97 0.7× 39 0.4× 36 0.5× 66 0.9× 40 1.1k
Xueling Yang China 17 139 0.8× 151 1.1× 113 1.1× 62 0.8× 153 2.0× 57 763
C. Andrew Day United States 9 85 0.5× 53 0.4× 57 0.6× 46 0.6× 74 1.0× 23 407
Zhiyuan Xu China 14 193 1.2× 87 0.6× 76 0.8× 56 0.7× 162 2.2× 57 711
Patrick J. Phelan United States 9 260 1.6× 156 1.2× 55 0.5× 141 1.8× 51 0.7× 14 855
Qijie Zhang China 16 218 1.3× 129 1.0× 125 1.2× 82 1.0× 104 1.4× 78 700

Countries citing papers authored by Jianping Wu

Since Specialization
Citations

This map shows the geographic impact of Jianping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Wu more than expected).

Fields of papers citing papers by Jianping Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Wu. The network helps show where Jianping Wu may publish in the future.

Co-authorship network of co-authors of Jianping Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianping Wu. A scholar is included among the top collaborators of Jianping Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianping Wu. Jianping Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Jie, et al.. (2025). Prognostic value of preoperative serum tumor markers in gallbladder cancer. BMC Gastroenterology. 25(1). 678–678.
2.
3.
4.
Liu, Quan, Meng Chen, Lichun Deng, et al.. (2022). Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial. Translational Lung Cancer Research. 11(5). 832–844. 8 indexed citations
5.
Mao, Weipu, Guangyuan Zhang, Si Sun, et al.. (2022). Development and validation of a prognostic nomogram for adult patients with renal sarcoma: A retrospective study based on the SEER database. Frontiers in Public Health. 10. 942608–942608. 3 indexed citations
6.
Liu, Chunhui, Weipu Mao, Zonghao You, et al.. (2022). Associations between exposure to different heavy metals and self-reported erectile dysfunction: a population-based study using data from the 2001-2004 National Health and Nutrition Examination Survey. Environmental Science and Pollution Research. 29(49). 73946–73956. 4 indexed citations
7.
Xue, Qian‐Li, et al.. (2022). Application value of fluorescence visualization-assisted technology in the resection of liver cancer: A systematic review and meta-analysis. Photodiagnosis and Photodynamic Therapy. 39. 102940–102940. 1 indexed citations
8.
Mao, Weipu, et al.. (2021). Prognostic nomogram for patients with lung metastatic renal cell carcinoma: a SEER-based study. Annals of Palliative Medicine. 10(3). 2791–2804. 12 indexed citations
9.
Li, Jing, Gui‐Shan Tan, Ruihuan Liu, et al.. (2021). A novel Apigenin derivative suppresses renal cell carcinoma via directly inhibiting wild-type and mutant MET. Biochemical Pharmacology. 190. 114620–114620. 12 indexed citations
10.
Mao, Weipu, Keyi Wang, Qiang Hu, et al.. (2021). Combination of Albumin-Globulin Score and Sarcopenia to Predict Prognosis in Patients With Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy. Frontiers in Nutrition. 8. 731466–731466. 12 indexed citations
11.
Liu, Ning, Xing Li, Weipu Mao, et al.. (2021). Relationship Between Blood Glucose and Hemoglobin A1c Levels and Urinary Incontinence in Women. International Journal of General Medicine. Volume 14. 4105–4116. 7 indexed citations
12.
Mao, Weipu, Si Sun, Ting He, et al.. (2021). Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort Study. Cancer Management and Research. Volume 13. 6437–6450. 10 indexed citations
13.
Zhou, Liuhua, Luwei Xu, Zheng Xu, et al.. (2017). Comparison of human adipose stromal vascular fraction and adipose-derived mesenchymal stem cells for the attenuation of acute renal ischemia/reperfusion injury. Scientific Reports. 7(1). 44058–44058. 36 indexed citations
14.
Ge, Yu‐Zheng, Ruiyang Wu, Hui Xin, et al.. (2015). A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma. Journal of Cancer Research and Clinical Oncology. 141(7). 1291–1299. 39 indexed citations
15.
Sun, Hongbin, et al.. (2014). Intensity of stromal changes is associated with tumor relapse in clinically advanced prostate cancer after castration therapy. Asian Journal of Andrology. 16(5). 710–710. 17 indexed citations
16.
Peng, Yu, Yu‐Zheng Ge, Yan Zhao, et al.. (2014). Identification and significance of mobilized endothelial progenitor cells in tumor neovascularization of renal cell carcinoma. Tumor Biology. 35(9). 9331–9341. 11 indexed citations
17.
Ge, Yu‐Zheng, Zheng Xu, Luwei Xu, et al.. (2014). Pathway analysis of genome-wide association study on serum prostate-specific antigen levels. Gene. 551(1). 86–91. 13 indexed citations
18.
Wu, Jianping, Jun Liu, Rui-Peng Jia, & Hongbin Song. (2013). Nur77 Inhibits Androgen-Induced Bladder Cancer Growth. Cancer Investigation. 31(10). 654–660. 20 indexed citations
19.
Wu, Jianping, et al.. (2007). Optimization of Head Impact Waveform to Minimize HIC. SAE technical papers on CD-ROM/SAE technical paper series. 1. 8 indexed citations
20.
Wu, Jianping, et al.. (2002). A Comparative Study: Immunohistochemical Detection of Cytosolic Thymidine Kinase and Proliferating Cell Nuclear Antigen in Breast Cancer. Cancer Investigation. 20(7-8). 922–931. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dandan He Breakdown of academic impact, for papers by Jianfeng Xu Breakdown of academic impact, for papers by Yufu Li Breakdown of academic impact, for papers by Francesca Bruno Breakdown of academic impact, for papers by Henry Penn Breakdown of academic impact, for papers by Xueling Yang Breakdown of academic impact, for papers by C. Andrew Day Breakdown of academic impact, for papers by Zhiyuan Xu Breakdown of academic impact, for papers by Patrick J. Phelan Breakdown of academic impact, for papers by Qijie Zhang
Rankless by CCL
2026